The use of force plate measurements to titrate the dosage of a new COX-2 inhibitor in lame horses

Equine Veterinary Journal

Volumn 41, Issue 3, 2009, Pages 309-312

  Back, W ^a,b   MacAllister, C G ^c   van Heel, M C V ^b   Pollmeier, M ^d   Hanson, P D ^d  

^a UTRECHT UNIVERSITY   (Netherlands)

^b GHENT UNIVERSITY   (Belgium)

^c OKLAHOMA STATE UNIVERSITY   (United States)

^d BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Horse; Kinetics; Lameness; Locomotion; NSAID; Pain relieving medication

Indexed keywords

EQUIDAE;

3 (CYCLOPROPYLMETHOXY) 4 (4 METHYLSULFONYLPHENYL) 5,5 DIMETHYLFURANONE; 3-(CYCLOPROPYLMETHOXY)-4-(4-METHYLSULFONYLPHENYL)-5,5-DIMETHYLFURANONE; CYCLOOXYGENASE 2 INHIBITOR; DRUG DERIVATIVE; GAMMA BUTYROLACTONE; NONSTEROID ANTIINFLAMMATORY AGENT; SULFONE;

ANIMAL; ANIMAL LAMENESS; ARTICLE; BIOMECHANICS; CLINICAL TRIAL; DOSE RESPONSE; FEMALE; FORELIMB; HORSE; HORSE DISEASE; MALE; MULTICENTER STUDY; PRESSURE;

4-BUTYROLACTONE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BIOMECHANICS; CYCLOOXYGENASE 2 INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FORELIMB; HORSE DISEASES; HORSES; LAMENESS, ANIMAL; MALE; PRESSURE; SULFONES;

EID: 67549090124     PISSN: 04251644     EISSN: None     Source Type: Journal    
DOI: 10.2746/042516409X397118     Document Type: Article

References (21)

1. Anon (1999) Guide to Veterinary Services for Horse Shows, 7th edn., American Association of Equine Practitioners, Lexington.
2. Back, W., Barneveld, A., van Weeren, P.R. and van den Bogert, A.J. (1993) Kinematic gait analysis in equine carpal lameness. Acta Anat. 146, 86-89.
3. Back, W., MacAllister, C.G, van Heel, M.C.V., Pollmeier, M. and Hanson, P.D. (2007) Vertical frontlimb ground reaction forces of sound and lame Warmbloods differ from those in Quarter horses. J. equine vet. Sci. 27, 123-129.
4. Bergh, M.S. and Budsberg, S.C. (2005) The coxib NSAIDs: potential clinical and pharmacologic importance in veterinary medicine. J. vet. int. Med. 19, 633-643.
5. Buchner, H.H.F. (2001) Gait adaptation in lameness. In: Equine Locomotion, Eds: W. Back and H.M. Clayton, W.B. Saunders, London. pp 251-279.
6. Clayton, H.M. and Schamhardt, H.C. (2001) Measurement techniques for gait analysis. In: Equine Locomotion, Eds: W. Back and H.M. Clayton, W.B. Saunders, London. pp 55-76.
7. Doucet, M.Y., Bertone, A.L., Hendrickson, D., Hughes, F., MacAllister, C., McClure, S., Reinemeyer, C., Rossier, Y., Sifferman, R., Vrins, A.A., White, G., Kunkle, B., Alva, B., Romano, R. and Hanson, P.D. (2008) Clinical efficacy and safety of firocoxib, a novel cyclooxygenase-2 inhibitor, compared to phenylbutazone as oral paste formulations in horses with naturally occurring osteoarthritis. J. Am. vet. med. Ass. 232, 91-97.
8. Erkert, R.S., MacAllister, C.G., Payton, M.E. and Clarke, C.R. (2005) Use of force plate analysis to compare the analgesic effects of intravenous administration of phenylbutazone and flunixin meglumine in horses with navicular syndrome. Am. J. vet. Res. 66, 284-288.
9. Goodrich, L.R., Furr, M.O., Robertson, J.L. and Warnick, L.D. (1998) A toxicity study of eltenac, a nonsteroidal anti-inflammatory drug, in horses. J. vet. Pharmacol. Ther. 21, 24-33.
10. Hu, H.H., MacAllister, C.G., Payton, M.E. and Erkert, R.S. (2005) Evaluation of the analgesic effects of phenylbutazone administered at a high or low dosage in horses with chronic lameness. J. Am. vet. med. Ass. 226, 414-417.
11. MacAllister, C.G., Morgan, S.J., Borne, A.T. and Pollet, R.A. (1993) Comparison of adverse effects of phenylbutazone, flunixin meglumine, and ketoprofen in horses. J. Am. vet. med. Ass. 202. 71-77.
12. McCann, M.E., Andersen, D.R., Brideau, C., Black, W.C., Zhang, D.-H. and Hickey, G.J. (2002) In vitro activity and in vivo efficacy of a novel Cox-2 inhibitor in the horse. J. vet. intern. Med. 16, 355.
13. Meschter, C.L., Gilbert, M., Krook, L., Maylin, G. and Corradino, R. (1990) The effects of phenylbutazone on the intestinal mucosa of the horse: a morphological, ultrastructural and biochemical study. Equine vet. J. 22, 255-263.
14. Monreal, L., Sabate, D., Segura, D., Mayos, I. and Homedes, J. (2004) Lower gastric ulcerogenic effect of suxibuzone compared to phenylbutazone when administered orally to horses. Res. vet. Sci. 76, 145-149.
15. Ramirez, S., Seahorn, T.L. and Williams, J. (1998) Renal medullary rim sign in 2 adult quarter horses. Can. vet. J. 39, 647-649.
16. Ross, M.W. and Dyson, S.J. (2003) Lameness in the Horse, W.B. Saunders, Philadelphia.
17. Schoonover, M.J., Jann, H.W. and Blaik, M.A. (2005) Quantitative comparison of three commonly used treatments for navicular syndrome in horses. Am. J. vet. Res. 66, 1247-1251.
18. Stashak, T.S. (2002) Examination of lameness. In: Adams' Lameness in Horses, 5th edn., Ed: T.S. Stashak, Lippincott Williams & Wilkins, Philadelphia. pp 113-182.
19. Symonds, K.D., MacAllister, C.G., Erkert, R.S. and Payton, M.E. (2006) Use of force plate analysis to assess the analgesic effects of etodolac in horses with navicular syndrome. Am. J. vet. Res. 67, 557-561.
20. Viitanen, M., Bird, J., Smith, R., Tulamo, R.M. and May, S.A. (2003) Biochemical characterisation of navicular hyaline cartilage, navicular fibrocartillage and the deep digital flexor tendon in horses with navicular disease. Res. vet. Sci. 75, 113-120.
21. Wright, I.M., Kidd, L. and Thorp, B.H. (1998) Gross, histological and histomorphometric features of the navicular bone and related structures in the horse. Equine vet. J. 30, 220-234.